Surgery Partners (SGRY) Competitors $22.60 -0.07 (-0.31%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$22.60 +0.00 (+0.02%) As of 05/22/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGRY vs. OPCH, GH, RDNT, BTSG, SHC, PRVA, CON, VCYT, LFST, and ARDTShould you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Veracyte (VCYT), LifeStance Health Group (LFST), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry. Surgery Partners vs. Option Care Health Guardant Health RadNet BrightSpring Health Services Sotera Health Privia Health Group Concentra Group Holdings Parent Veracyte LifeStance Health Group Ardent Health Partners Option Care Health (NASDAQ:OPCH) and Surgery Partners (NASDAQ:SGRY) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, community ranking, valuation and institutional ownership. Do insiders & institutionals believe in OPCH or SGRY? 98.1% of Option Care Health shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by insiders. Comparatively, 2.3% of Surgery Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, OPCH or SGRY? Option Care Health has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOption Care Health$5.19B1.01$267.09M$1.2425.83Surgery Partners$3.17B0.91-$11.90M-$1.53-14.77 Does the MarketBeat Community believe in OPCH or SGRY? Surgery Partners received 250 more outperform votes than Option Care Health when rated by MarketBeat users. However, 64.00% of users gave Option Care Health an outperform vote while only 57.83% of users gave Surgery Partners an outperform vote. CompanyUnderperformOutperformOption Care HealthOutperform Votes6464.00% Underperform Votes3636.00% Surgery PartnersOutperform Votes31457.83% Underperform Votes22942.17% Does the media refer more to OPCH or SGRY? In the previous week, Option Care Health had 4 more articles in the media than Surgery Partners. MarketBeat recorded 11 mentions for Option Care Health and 7 mentions for Surgery Partners. Option Care Health's average media sentiment score of 1.89 beat Surgery Partners' score of 1.42 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Surgery Partners 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, OPCH or SGRY? Option Care Health has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Surgery Partners has a beta of 1.96, meaning that its stock price is 96% more volatile than the S&P 500. Is OPCH or SGRY more profitable? Option Care Health has a net margin of 4.37% compared to Surgery Partners' net margin of -2.03%. Option Care Health's return on equity of 15.30% beat Surgery Partners' return on equity.Company Net Margins Return on Equity Return on Assets Option Care Health4.37% 15.30% 6.57% Surgery Partners -2.03%2.85%1.22% Do analysts recommend OPCH or SGRY? Option Care Health currently has a consensus price target of $35.50, suggesting a potential upside of 10.83%. Surgery Partners has a consensus price target of $34.75, suggesting a potential upside of 53.76%. Given Surgery Partners' higher possible upside, analysts plainly believe Surgery Partners is more favorable than Option Care Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Option Care Health 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Surgery Partners 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.78 SummaryOption Care Health beats Surgery Partners on 13 of the 17 factors compared between the two stocks. Get Surgery Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGRY vs. The Competition Export to ExcelMetricSurgery PartnersGeneral medical & surgical hospitals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.91B$13.69B$5.33B$8.39BDividend YieldN/A0.58%5.21%4.11%P/E Ratio-47.087.1026.7919.70Price / Sales0.910.60393.69121.79Price / Cash14.306.8638.2534.62Price / Book0.9434.976.774.50Net Income-$11.90M$1.20B$3.23B$248.22M7 Day Performance-5.60%-4.02%0.42%-0.80%1 Month Performance6.55%16.65%9.06%11.52%1 Year Performance-7.53%12.72%18.55%8.99% Surgery Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGRYSurgery Partners2.7872 of 5 stars$22.60-0.3%$34.75+53.8%-10.3%$2.91B$3.17B-47.0812,200OPCHOption Care Health4.2154 of 5 stars$31.86+0.1%$35.50+11.4%+10.3%$5.22B$5.19B26.775,600Positive NewsGHGuardant Health4.645 of 5 stars$41.66-0.1%$52.32+25.6%+64.6%$5.16B$774.00M-11.701,790Positive NewsRDNTRadNet3.3688 of 5 stars$57.03+2.3%$69.75+22.3%-2.2%$4.28B$1.83B-814.608,970News CoverageAnalyst DowngradeBTSGBrightSpring Health Services1.6307 of 5 stars$22.35-2.1%$22.89+2.4%+99.7%$3.89B$11.86B-85.9635,000Positive NewsHigh Trading VolumeSHCSotera Health2.9333 of 5 stars$13.50+2.8%$15.80+17.0%+9.0%$3.83B$1.11B54.003,000Positive NewsPRVAPrivia Health Group3.5673 of 5 stars$25.06+0.2%$27.38+9.3%+40.5%$3.04B$1.80B250.63810Positive NewsCONConcentra Group Holdings ParentN/A$21.66+1.2%$28.50+31.6%N/A$2.76B$1.90B16.1611,000Positive NewsEx-DividendVCYTVeracyte3.9484 of 5 stars$30.76+3.5%$40.90+33.0%+26.7%$2.41B$445.76M-205.07790Gap UpLFSTLifeStance Health Group2.495 of 5 stars$5.85+2.1%$8.30+41.9%-3.1%$2.27B$1.28B-22.506,640ARDTArdent Health Partners3.2371 of 5 stars$14.85+2.3%$20.75+39.7%N/A$2.12B$6.02B9.1124,200Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Option Care Health Competitors Guardant Health Competitors RadNet Competitors BrightSpring Health Services Competitors Sotera Health Competitors Privia Health Group Competitors Concentra Group Holdings Parent Competitors Veracyte Competitors LifeStance Health Group Competitors Ardent Health Partners Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SGRY) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.